Japanese Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

3 companies

Kidswell Bio

Market Cap: JP¥9.4b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

4584

JP¥214.00

20.9%

71.2%

GNI Group

Market Cap: JP¥215.4b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

2160

JP¥4,290.00

44.4%

94.7%

Japan Tissue Engineering

Market Cap: JP¥23.8b

Engages in the regenerative medicine business in Japan.

7774

JP¥585.00

5.4%

-14.7%

	
		OSZAR »